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Abstract 1 
Background: Sedentary behaviour is linked to increased cardiovascular disease risk in 2 
Rheumatoid Arthritis (RA), but the biological processes underlying this relationship are not 3 
understood. Objectives: To investigate the cross-sectional associations of habitual sedentary 4 
behaviour, with endothelial function in RA. Methods: Sixty-eight RA patients (Mage = 55±12 5 
years) underwent Laser Doppler Imaging with iontophoresis, to assess microvascular 6 
endothelium-dependent (acetylcholine, ACh) and endothelium-independent (sodium 7 
nitroprusside, SNP) function. Large-vessel endothelium-dependent and endothelium-independent 8 
functions were measured via flow-mediated dilation (FMD) and glyceryl trinitrate dilation (GTN), 9 
respectively. Habitual sedentary behaviour (hours/week sitting) was self-reported (International 10 
Physical Activity Questionnaire). Results: Regressions revealed sitting time significantly 11 
negatively predicted microvascular endothelium-dependent function (ACh, unstandardizedβ = − 3.25, p 12 
= .02, 95% CI [– 6.07, – .42], R2 = 0.06), but did not associate with other endothelial function 13 
outcomes (SNP, FMD, GTN). Conclusion: Habitual sitting time appears to be adversely linked to 14 
microvascular endothelium-dependent function among people living with RA.  15 
 16 
Keywords: Sedentary behaviour; Rheumatoid arthritis; Endothelial function; Cardiovascular 17 
disease; Ultrasonography. 18 
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Introduction 1 
Cardiovascular disease (CVD)1 is the leading cause of death among people living with 2 
Rheumatoid Arthritis (RA) [1], with RA increasing CVD risk by ~50% compared to the 3 
general population [2]. High levels of sedentary behaviour (waking behaviour ≤1.5 metabolic 4 
equivalents, whilst sitting/lying) are linked to increased CVD risk in RA, independently of the 5 
benefits of physical activity [3]. Whilst the biological mechanisms underlying this adverse 6 
relationship are not yet known, recent experimental work suggests endothelial dysfunction 7 
may play an important role [4].  8 
The endothelium maintains vascular homeostasis by regulating vascular tone and anti-9 
atherosclerotic processes via the release of vasodilator molecules, such as nitric oxide (NO), 10 
prostacyclin (PGI2) and endothelium derived hyperpolarizing factor (EDHF) [5]. Several 11 
non-invasive assessments of NO-mediated vasodilation (i.e., endothelium–dependent 12 
function) can be conducted in the microvessels and large-vessels, and provide early indication 13 
of future CVD risk in the general population [6]. RA patients also have endothelial 14 
dysfunction which likely results from subtle interactions between inflammation and classical 15 
CVD risk factors [7], adversely affecting downstream endothelium-independent vasodilatory 16 
processes (i.e., smooth muscle cell integrity).[5] Indeed, RA patients exhibit poor 17 
microvascular perfusion in the coronary circulation, even when the larger epicardial arteries 18 
are clear, which suggests that different vascular beds are affected differently by RA-related 19 
factors [8]. However at present, it is not clear which factors affect the specific vascular 20 
outcomes in RA (i.e., endothelium-dependent vs. independent function in the small vs. large-21 
vessels), and identification of such factors (e.g., the role of sedentary behaviour) is necessary 22 
to inform effective CVD prevention in this high-risk population. 23 
To date, the majority of research investigating the implications of sedentary behaviour 24 
for endothelial function, has employed experimental designs to examine the effects of 25 
prolonged sitting (i.e., 3-5 hours uninterrupted sitting in a laboratory) on large-vessel 26 
endothelium-dependent function in healthy males [9]. Research investigating the impact of 27 
more habitual (daily) sedentariness on microvascular and large-vessel endothelial function is 28 
required to better evaluate its role in the development of CVD. This is important to 29 
investigate in RA specifically, as the mechanisms that drive vascular dysfunction may differ 30 
to those in healthy adults [10].  31 
The aim of this study was therefore to examine the cross-sectional associations 32 
between habitual sedentary behaviour, with microvascular and large-vessel endothelium-33 
dependent, and endothelium-independent function, in patients with RA. The data presented 34 
herein represents secondary analysis of previously published data, reporting associations 35 
between CVD risk and endothelial function in this cohort [11].  36 
Materials and Methods 37 
Ninety-eight RA patients were recruited from Rheumatology outpatient clinics at Russells 38 
Hall Hospital (Dudley Group NHS Foundation Trust). All patients recruited met the 1987 RA 39 
criteria of the American College of Rheumatology. Informed consent was obtained from all 40 
individual participants included in the study. Ethical approval was granted by the local 41 
National Health Service Research Ethics Committee (approval number:10/H1206/59).  42 
1 CVD, cardiovascular disease; RA, Rheumatoid Arthritis; NO, Nitric Oxide; DAS, Disease 
Activity Score; ESR, Erythrocyte Sedimentation Rate; HAQ, Health Assessment Questionnaire; 
ACh, Acetylcholine; SNP, sodium nitroprusside; FMD, Flow Mediated Dilation; GTN, Glyceryl-
trinitrate.  
                                                             
 3 
Participants reported to a temperature-controlled vascular laboratory (22°C) to 1 
complete assessments, in a fasted state (12-hours) having refrained from exercise for 24hrs.  2 
RA characteristics; Disease activity was assessed using the Disease Activity Score in 28-3 
joints (DAS28) and erythrocyte sedimentation rate (ESR). Disease severity was measured via 4 
the Stanford Health Assessment Questionnaire (HAQ). Use of vasoactive medication (i.e., 5 
anti-hypertensives, beta-blockers and/or calcium channel blockers) was self-reported and 6 
corroborated with medical notes. 7 
Global (10-year) CVD risk; QRISK2 was used to indicate ten-year CVD risk. QRISK2 score 8 
was calculated using participants; age, gender, height, weight, blood pressure, cholesterol 9 
(total/HDL ratio), smoking status, diabetic status, presence of kidney disease and family 10 
history of heart disease [11].  11 
Endothelial function; First, microvascular endothelial function was assessed non-invasively in 12 
the forearm, using Laser Doppler Imaging with iontophoresis of 1% Acetylcholine (ACh, 13 
endothelium-dependent function) and 1% sodium nitroprusside (SNP, endothelium-14 
independent function), in 2.5ml solution containing 0.5% saline, according to previously 15 
established guidelines [12]. Following this, large vessel endothelium-dependent (flow 16 
mediated dilatation, FMD) and endothelium-independent (sublingual glyceryl-trinitrate, 17 
GTN) function, were measured using high-resolution Doppler Ultrasonography of the 18 
brachial artery [12]. Assessments of microvascular endothelial function were conducted first, 19 
as both FMD and GTN may affect blood flow in the forearm, and therefore iontophoresis 20 
measurements. Large vessel endothelium-independent function was assessed last, as 21 
administration of GTN causes systemic vasodilation, which would affect all preceding 22 
vascular tests.  23 
Endothelial function was expressed as the percentage increase in perfusion or diameter 24 
from baseline. A single observer conducted all vascular assessments (AS), reporting intra-25 
observer coefficients of variation of 6.5% (ACh), 5.9% (SNP), 10.7% (FMD) and 11.8% for 26 
(GTN). Data for ACh/SNP and GTN were not collected from 3 participants due to technical 27 
problems with equipment. 28 
Sitting time; Habitual sitting-time was self-reported using the International Physical Activity 29 
Questionnaire (IPAQ). Participants reported their average time spent sitting on; 1) weekdays, 30 
and 2) weekend days (i.e., at home, whilst studying, leisure time), over the previous 7-days. 31 
Total weekly sitting time (hours/week) was computed; (weekday sitting time x 5) + (weekend 32 
day sitting time x 2).  33 
Of the initial 98 participants recruited, 30 were excluded on the basis of missing IPAQ 34 
data (n = 27, missing data = 28%), or as extreme outliers (ACh/SNP, n = 3). Following these 35 
exclusions, missing data were < 5% for; QRISK2 = 2, DAS28 = 2, HAQ = 1, ACh/SNP = 3, 36 
GTN = 2). Missing values were therefore imputed to maximise statistical power (expectation 37 
maximisation method), retaining a final sample of n = 68 for statistical analyses. Participants 38 
in this final sample were not significantly different to those excluded (n = 30) for all targeted 39 
variables (Table 1).  40 
Cross-sectional associations between habitual sitting time and endothelial function 41 
outcomes were examined via multiple regression analyses, in conjunction with bootstrapping. 42 
Bootstrap-generated 95% bias-corrected confidence intervals were constructed for 5000 43 
samples [13], and analyses were adjusted for RA characteristics, global CVD risk, and 44 
vasoactive medication. Bootstrapping is a non-parametric resampling procedure reported to 45 
be superior to alternative tests with respect to Type 1 error rates and power (Table 1).[13] 46 
Analysis was performed using SPSS (version 24.0). 47 
 4 
 1 
Results 2 
Descriptive statistics are reported in Table 1. The sample was largely female, with moderate 3 
disease activity and moderate-to-severe disability. Regression analysis (Table 2) revealed 4 
habitual sitting time was significantly negatively related to microvascular endothelium-5 
dependent function (ACh, unstandardizedβ = − 3.25, p = .02), but not microvascular endothelium-6 
independent function (SNP, unstandardizedβ = − 1.94, p = .07). Sitting time accounted for 6% of 7 
the variance in microvascular endothelium-dependent function, with the total model 8 
explaining 18% of the variance in this outcome. Habitual sitting time did not significantly 9 
predict large-vessel endothelium-dependent vasodilation (FMD, unstandardizedβ = .01, p = .84) or 10 
independent vasodilation (GTN, unstandardizedβ = −.06, p = .37). 11 
Discussion 12 
This is the first study to reveal that higher self-reported sitting time is predictive of impaired 13 
microvascular endothelium-dependent function among people with RA. This cross-sectional 14 
association was observed after adjusting for global CVD risk, RA characteristics and 15 
vasoactive medication. Results provide new evidence to suggest “too much sitting” may be 16 
linked to poorer endothelial function, and contribute toward increased CVD risk in RA [1, 3].  17 
A recent experimental study in healthy males reported significantly reduced 18 
hyperaemic response in the microvessels, but not the large-vessels of the brachial artery, 19 
following 6-hours of uninterrupted sitting [14]. Our results build on this work, to suggest that 20 
habitual sedentarity [i.e., repeated episodes of prolonged (uninterrupted) sitting], may lead to 21 
chronic impairments in peripheral microvascular endothelium-dependent function among 22 
people living with RA. In addition, these data strengthen the suggestion that the peripheral 23 
microvasculature may be more vulnerable to the adverse consequences of sedentary 24 
behaviour, relative to the large-vessels.  25 
Reduced blood flow and associated shear rate are the mechanisms proposed to 26 
underlie the association between sitting and microvascular endothelium-dependent 27 
dysfunction. That is, in the absence of muscle activation (e.g., during low-energy sitting), 28 
peripheral vascular blood flow and shear rate are reduced [14], which in turn may lead to 29 
reduced NO bioavailability, and reduced vasodilatory function of the microvasculature [4, 9, 30 
14]. Through such mechanisms, high levels of sitting time may perpetuate an already 31 
unfavourable CVD profile, and further contribute towards promoting vascular dysfunction 32 
and cardiovascular co-morbidity in RA. Indeed, vascular dysfunction in the peripheral 33 
circulation is reported to be a good predictor of long-term cardiovascular events in individuals 34 
with atherosclerosis, and healthy older participants [15, 16].  35 
The impact of sitting on microvascular but not large-vessel endothelial function could 36 
be due to the microvessels comprising the largest proportion of the vasculature [17]. Thus, the 37 
microvasculature is likely to have greater exposure to damaging stimuli - e.g., the 38 
physiological processes associated with sedentary behaviour. As such, repeated episodes of 39 
sedentary behaviour may compromise the function of the microvessels, prior to (and to a 40 
greater extent than), any observed impairments in the large-vessels. Indeed, microvascular 41 
abnormalities can occur before, or alongside the development of CVD risk factors in healthy 42 
individuals, and among those with hypertension [18-20]. Coronary microvascular disease is 43 
also apparent in the absence of large-vessel disease in RA [8].  44 
Our study did not demonstrate associations between habitual sitting time and 45 
endothelium-independent microvascular and large-vessel function in RA. This may suggest 46 
that the adverse effects of sitting relate primarily to the functionality of the endothelial cells 47 
 5 
themselves (i.e., NO availability), rather than the integrity of the smooth muscle cells to relax 1 
[5]. However, this study reports secondary analysis of an existing data set, which may be 2 
underpowered to detect such associations. Indeed, standardised effect sizes were comparable 3 
for endothelium-dependent and endothelium–independent microvascular function outcomes 4 
(Table 2 legend). Thus, studies designed specifically to assess the role of sitting for 5 
endothelium-independent function in RA are required. Other limitations to this study include 6 
a cross-sectional design and a reliance on self-reported sedentary behaviour. Larger 7 
prospective and experimental studies utilising objective measurement devices are therefore 8 
required to confirm current findings. Insights regarding the specific mechanisms by which 9 
sitting time may lead to endothelial dysfunction in RA may be provided by experimental 10 
studies that compare this clinical population with healthy controls.   11 
In conclusion, habitual self-reported sitting time appears to be associated with 12 
microvascular endothelium-dependent function in people with RA, but not large-vessel 13 
endothelial function. Results highlight the importance of experimental studies to confirm 14 
whether sedentary behaviour represents a modifiable risk factor for CVD in RA. 15 
 16 
References 17 
 18 
1. Kitas GD, Gabriel SE (2011). Cardiovascular disease in rheumatoid arthritis: state of the art 19 
and future perspectives. Ann Rheum Dis, 70:8-14. 20 
2.  Agca R, Heslinga SC, Rollefstad S et al. (2017). EULAR recommendations for cardiovascular 21 
disease risk management in patients with rheumatoid arthritis and other forms of inflammatory 22 
joint disorders: 2015/2016 update. Ann Rheum Dis, 76:17-28. 23 
3.  Fenton SAM, Veldhuijzen van Zanten JJCS, Kitas GD et al. (2017). Sedentary behaviour is 24 
associated with increased long-term cardiovascular risk in patients with rheumatoid arthritis 25 
independently of moderate-to-vigorous physical activity. BMC Musculoskelet Disord, 18:131. 26 
4.  Carter S, Hartman Y, Holder S (2017). Sedentary Behavior and Cardiovascular Disease Risk: 27 
Mediating Mechanisms. Exerc Sport Sci Rev, 45:80-86. 28 
5.  Sandoo A, Veldhuijzen van Zanten JJCS, Metsios GS et al. (2010). The endothelium and its 29 
role in regulating vascular tone. Open Cardiovasc Med, 4:302-312. 30 
6.  Lerman A, Zeiher AM (2005). Endothelial function: cardiac events. Circulation, 111: 363-368. 31 
7.  Sandoo A, Veldhuijzen van Zanten JJCS, Metsios GS et al. (2011). Vascular function and 32 
morphology in rheumatoid arthritis: a systematic review. Rheumatology (Oxford), 50:2125-33 
2139. 34 
8.  Toutouzas K, Sfikakis PP, Karanasos A et al. (2013) Myocardial ischaemia without obstructive 35 
coronary artery disease in rheumatoid arthritis: hypothesis-generating insights from a cross-36 
sectional study. Rheumatology (Oxford), 52:76-80. 37 
9.  Trinity JD (2017). Something is definitely better than nothing: simple strategies to prevent 38 
vascular dysfunction. Clin Sci (Lond), 13:1055-1058. 39 
10.  Grace MS, Climie RE, Dunstan DW (2017). Sedentary Behavior and Mechanisms of 40 
Cardiovascular Disease-Getting to the Heart of the Matter. Exerc Sport Sci Rev, 45:55-56. 41 
11.  Sandoo A, Kitas GD, Carroll D et al. (2012). The role of inflammation and cardiovascular 42 
disease risk on microvascular and macrovascular endothelial function in patients with 43 
rheumatoid arthritis: a cross-sectional and longitudinal study. Arthritis Res Ther, 14:R117. 44 
12.  Sandoo A, Kitas GD (2015). A methodological approach to non-invasive assessments of 45 
vascular function and morphology. J Vis Exp, 96:e52339. 46 
13.  Shrout PE, Bolger N (2002). Mediation in experimental and nonexperimental studies: new 47 
procedures and recommendations. Psychol Methods, 7:422-445. 48 
14.  Restaino RM, Holwerda SW, Credeur DP et al. (2015). Impact of prolonged sitting on lower 49 
and upper limb micro- and macrovascular dilator function. Exp Physiol, 100:829-838. 50 
 6 
15.  Gokce N, Keaney JF. Jr, Hunter LM et al. (2003). Predictive value of noninvasively 1 
determined endothelial dysfunction for long-term cardiovascular events in patients with 2 
peripheral vascular disease. J Am Coll Cardiol, 41:1769-1775. 3 
16.  Schachinger V, Britten MB, Zeiher AM (2000). Prognostic impact of coronary vasodilator 4 
dysfunction on adverse long-term outcome of coronary heart disease. Circulation, 101:1899-5 
1906. 6 
17.  Krentz AJ, Clough G, Byrne CD (2009). Vascular disease in the metabolic syndrome: do we 7 
need to target the microcirculation to treat large vessel disease? J Vasc Res, 46:515-526. 8 
18.  McVeigh GE, Bratteli CW, Morgan DJ et al. (1999). Age-related abnormalities in arterial 9 
compliance identified by pressure pulse contour analysis: aging and arterial compliance. 10 
Hypertension, 33:1392-1398. 11 
19.  Giannattasio C, Cattaneo BM, Mangoni AA et al. (1995). Cardiac and vascular structural 12 
changes in normotensive subjects with parental hypertension. J Hypertens, 13:259-264. 13 
20.  Longhini CS, Scorzoni D, Bazzanini F et al. (1997). The structural arteriolar changes in 14 
diabetes mellitus and essential hypertension. The relative contribution of ageing and high 15 
blood pressure. Eur Heart J, 18:1135-1140. 16 
 17 
 18 
 7 
Table 1. Descriptive statistics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: ¶ = Non-normally distributed data (Kolmogorov-Smirnov p <.05). Log transformations did not reduce skewness in the case 
of HAQ. Consequently, non-parametric tests (i.e., Mann-Whitney (M-W) U, bootstrapping) were used in subsequent analyses 
that included non-normally distributed data.  
 
Data is presented following imputation of missing values for the final sample of n = 68 participants included in regression 
analyses. Participants included were not significantly different from those excluded for; age (t (92) = −1.20), gender (χ² (1) = 
.10), all endothelial function outcomes (ACh (M-W U = −1.40); SNP (M-W U = −.76); FMD (t (90) = 1.11); GTN (t (89) = .35), 
QRISK2 (M-W U = .25), RA characteristics (DAS28 (t (90) = .13); HAQ (M-W U = 1.76)), vasoactive medication (χ² (1) = .31) 
[all p = >.08] 
                     Mean ± SD 
                     n = 68 
             Range  
             (min – max) 
 
Age (years) 
 
                  55 ± 12 
 
                   24 – 77  
Gender (% female)                         74%    
Height (cm)                    164.0 ± 9.3  142.0 – 190.0  
Weight (kg)       80.8 ± 18.2  48.7 – 122.9  
RA characteristics    
Disease activity (DAS28)  3.56 ± 1.37                     0.14 – 7.00  
¶Disease severity (HAQ)  1.59 ± 0.88                    0 – 3  
Vasoactive medication (% yes)                     47%   
CVD risk factors    
Total cholesterol (mmol/L)                 4.9 ± 1.0                    3.0 – 7.1  
HDL cholesterol (mmol/L)                 1.4 ± .35                    0.8 – 2.4  
Systolic blood pressure (mmHg)               130 ± 17                      93 – 165  
Diastolic blood pressire (mmHg)                 80 ± 10                      58 – 105  
Body-mass-index (kg/m2)               30.2 ± 6.4                    20.3 – 45.9  
Smoker (% current smokers)                  19%   
Diabetes (% yes)                   6%   
Kidney Disease (% yes)                   2%   
Family history of heart disease (% yes)                  47%   
¶QRISK2 (%) 18.4 ± 14.2                    0 – 66  
Endothelial function    
Microvascular function    
           ¶Endothelium-dependent (ACh)                 316 ± 212                    − 3 – 908  
           ¶Endothelium-independent (SNP)                 302 ± 180                  − 4 – 832  
Large-vessel function    
          Endothelium-dependent (FMD)                9.4 ± 5.9                 − 1.4 – 23.0  
          Endothelium-independent (GTN)              22.9 ± 8.5                   4.8 – 44.4  
Sitting time    
Weekday (hours)                5.5 ± 2.8                   1.0 – 13.0  
Weekend day (hours)                5.8 ± 2.6                  1.5 – 13.0  
Total weekly (hours)                38.9 ± 18.3                10.5 – 91.0  
 8 
Table 2.  Results of regression analyses examining associations between self-reported sitting time and endothelial function outcomes. 
 
 
Note: RA patients were recruited from Russells Hall Hospital between September 2008 and September 2010 
 
β = bootstrapped path coefficients (unstandardized), * p <.05, ** p <.01. The 95% bootstrap bias corrected confidence intervals are reported (95% CI [upper, lower]). R2 = variance in endothelial function 
explained by predictor variable. For Total Model 1, p = significance of model. For Total Model 2, p = significance of R2 change.  
 
Model 1 = relationships between global CVD risk, RA characteristics, and vasoactive medication with endothelial function. 
Model 2 = associations between total weekly sitting time and endothelial function adjusting for factors in Model 1. Relationships reported in Model 2 were unchanged where non-bootstrapped regressions were 
computed. Standardised (non-bootstrapped) coefficients for the relationships between sitting time and endothelial function outcomes were; ACh, β = − .28, p = .03; SNP, β = − .20, p = .14; FMD, β = .03, p = 
.84; GTN, β = − .12, p = .32 
 
CVD = Cardiovascular Disease; DAS28 = Disease Activity Score 28; HAQ = Health Assessment Questionnaire; ACh = Acetylcholine; SNP = Sodium Nitroprusside; FMD = Flow Mediated Dilation; GTN = 
Glyceryl Trinitrate. 
 
ACh SNP FMD GTN 
       β p      95% CI R2       β p      95% CI R2       β p 95% CI R2      β p 95% CI R2 
[upper, lower]      [upper, lower] [upper, lower]        [upper, lower] 
 
Model 1 
                
Global CVD risk (Q-risk2) – 4.81 .02* – 8.62, – 1.58 .10 – 2.03 .28 – 5.83, 1.16 .01 – .11 .13 – .24, .01 .05 – .25 .00** – .36, – .14 .24 
Disease activity (DAS28) 20.75 .26 – 13.67, 55.50 .02 7.74 .68 – 25.45, 48.00 .01 .44 .52 – .91, 1.61 .01 – .25 .79 – 2.13, 1.38 .00 
Disease severity (HAQ) – 1.94 .95 – 74.37, 58.29 .00 – 57.38 .08 – 119.42, – 1.46 .05 .13 .90 – 1.72, 2.21 .00 1.50 .25 – .94, 4.52 .01 
Vasoactive medication  – 12.68 .79 – 111.69, 87.89 .00 – 40.96 .32 – 117.86, 37.55 .01 – 1.30 .30 – 3.49, .93 .01 3.83 .04* .56, 7.16 .05 
 
Total Model 1 
  
.09 
  
.12 
  
.23 
  
.08 
  
.28 
  
.07 
  
.00** 
  
.30 
                 
Model 2                 
Sitting time (hours/week) – 3.25 .02* – 6.07, – .42 .06 – 1.94 .07 – 4.32,  –.14 .03 .01 .84 – .08, .10 .00 – .06 .37 – .17, .06 .01 
 
Total Model 2 
  
.03* 
  
.18 
  
.14 
  
.11 
  
.84 
  
.07 
  
.32 
  
.31 
